Novartis and Novo Nordisk Trials Lower Biomarkers but Fail to Improve Outcomes
Two major trials show drugs can lower markers like lipoprotein(a) and IL-6 without changing patient outcomes. A moment of reckoning for preventive cardiology.
CLAY TRIBUNE / THE ARCHIVE
Tag: clinical trials
Enveda Raises $311M Series E to Advance Nature-Derived AI Drugs Through Clinical Trials
Enveda raises $311M to advance AI-discovered nature-derived drugs into clinical trials, valuing the biotech at $2B.
Pfizer, Valneva Lyme Vaccine Advances Through EMA Review After Statistical Hiccup
Pfizer and Valneva push Lyme vaccine through EMA review despite trial's shaky statistical footing.
AI uncovers hidden Ozempic side effects across 400,000 Reddit posts
A tale of Reddit posts and AI, wherein two professors of Penn discover hidden side effects of Ozempic and Mounjaro among many thousands.
Ovid Therapeutics Hands Off Soticlestat to Fund Its Next Two Lead Programs
Ovid Therapeutics hands off soticlestat to fund OV4071 and OV329 pipeline, trading direct control for milestone payments.